INVESTORS

Corporate Profile

KALA BIO is a clinical-stage biopharmaceutical company on a mission. Guided by advanced science and an ever-climbing optimism, we’re focused on solving rare and serious eye diseases through research and development of innovative therapies. KALA BIO is a leader in the emerging field of mesenchymal stem cell secretome (MSC-S) therapy. Using our proprietary MSC-S platform, we are developing therapies with regenerative healing effects for rare ocular surface and retinal diseases, with the ultimate goal of preserving vision and changing lives.